Back

Incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: the single centre experience

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Diagnosis and prognosis of HFpEF Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Milena Pandrc

Military Medical Academy of Belgrade, Belgrade (Serbia)

3 More presentations in this session

Presentation thumbnail
Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis
Associate Professor A. Briasoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Differences in heart failure with preserved ejection fraction diagnostic and therapeutic practices between physicians from europe and the middle east and north africa: an international survey
Professor H. Alarfaj (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
Miss A. Achten (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and prognosis of HFpEF

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Influence of persistent atrial fibrillation on the prognosis of heart failure with preserved, mildly reduced, and reduced ejection fraction in women and men.
thumbnail
Congress Presentation
Inflammation and arterial hypertension are the main risk factors occurrence of AF in patients with heart failure patients with preserved ejection fraction (retrospective study)
thumbnail
Congress Presentation
Effects of atrial fibrillation ablation in patients with heart failure: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources